These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
6. [Familial ovarian cancer syndrome]. Bösze P Orv Hetil; 1994 Feb; 135(9):459-64. PubMed ID: 8139849 [TBL] [Abstract][Full Text] [Related]
7. Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry. Werness BA; Ramus SJ; DiCioccio RA; Whittemore AS; Garlinghouse-Jones K; Oakley-Girvan I; Tsukada Y; Harrington P; Gayther SA; Ponder BA; Piver MS Int J Gynecol Pathol; 2004 Jan; 23(1):29-34. PubMed ID: 14668547 [TBL] [Abstract][Full Text] [Related]
8. Cancer of the ovary. Constable WC; Birrell WR; Truskett ID Surg Gynecol Obstet; 1969 Feb; 128(2):294-300. PubMed ID: 4180453 [No Abstract] [Full Text] [Related]
9. The impact of family history on ovarian cancer risk. The Utah Population Database. Kerber RA; Slattery ML Arch Intern Med; 1995 May; 155(9):905-12. PubMed ID: 7726698 [TBL] [Abstract][Full Text] [Related]
10. Trends in incidence of and mortality from uterine and ovarian cancer in Mid and South Limburg, The Netherlands, 1986-2003. Kellert IM; Botterweck AA; Huveneers JA; Dirx MJ Eur J Cancer Prev; 2009 Feb; 18(1):85-9. PubMed ID: 19077569 [TBL] [Abstract][Full Text] [Related]
12. Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group. Pharoah PD; Easton DF; Stockton DL; Gayther S; Ponder BA Cancer Res; 1999 Feb; 59(4):868-71. PubMed ID: 10029077 [TBL] [Abstract][Full Text] [Related]
13. BRCA1 genetic mutation and its link to ovarian cancer: implications for advanced practice nurses. Brunsvold AN; Wung SF; Merkle CJ J Am Acad Nurse Pract; 2005 Dec; 17(12):518-26. PubMed ID: 16293160 [TBL] [Abstract][Full Text] [Related]
14. Accuracy of self-reported family history of cancer in a large case-control study of ovarian cancer. Soegaard M; Jensen A; Frederiksen K; Høgdall E; Høgdall C; Blaakaer J; Kjaer SK Cancer Causes Control; 2008 Jun; 19(5):469-79. PubMed ID: 18197461 [TBL] [Abstract][Full Text] [Related]
15. Age at onset of ovarian cancer in women with a strong family history of ovarian cancer. Goldberg JM; Piver MS; Jishi MF; Blumenson L Gynecol Oncol; 1997 Jul; 66(1):3-9. PubMed ID: 9234912 [TBL] [Abstract][Full Text] [Related]
16. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589 [TBL] [Abstract][Full Text] [Related]
17. Comparative study of ovarian cancer histopathology by registry pathologists and referral pathologists: a study by the Gilda Radner Familial Ovarian Cancer Registry. Piver MS; Tsukada Y; Werness BA; DiCioccio RA; Whittemore AS; Ponder BA Gynecol Oncol; 2000 Aug; 78(2):166-70. PubMed ID: 10926797 [TBL] [Abstract][Full Text] [Related]
18. [Ovarian cancer: the symptoms and pathology. The cases of the Cantonal Cancer Registry (1989-1995)]. Petignat P; Gaudin G; Vajda D; Joris F; Obrist R Schweiz Med Wochenschr; 1997 Nov; 127(48):1993-9. PubMed ID: 9490466 [TBL] [Abstract][Full Text] [Related]